Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.


TSXV:MPH - Post by User

Bullboard Posts
Post by krazyon May 10, 2005 9:20am
264 Views
Post# 9013754

CEO ================ MPH

CEO ================ MPHIS BUYING LOTS ........ Latest 10 Filings:: Medicure Inc. (MPH) As of May 9th, 2005 Important disclaimer, please click here or see below Filing Date Transaction Date Insider Name Nature of transaction Securities # or value acquired or disposed of Unit Price May 09/05 May 05/05 Friesen, Albert David 10 - Acquisition in the public market Common Shares 10,000 $0.890 May 09/05 May 05/05 Friesen, Albert David 10 - Acquisition in the public market Common Shares 10,000 $0.880 May 09/05 May 05/05 Friesen, Albert David 10 - Acquisition in the public market Common Shares 10,000 $0.930 May 09/05 May 05/05 Friesen, Albert David 10 - Acquisition in the public market Common Shares 25,000 $0.900 May 09/05 May 05/05 Friesen, Albert David 10 - Acquisition in the public market Common Shares 20,000 $0.940 May 09/05 May 05/05 Friesen, Albert David 10 - Acquisition in the public market Common Shares 36,000 $0.920 May 09/05 May 04/05 Friesen, Albert David 10 - Acquisition in the public market Common Shares 25,000 $0.910 May 09/05 May 04/05 Friesen, Albert David 10 - Acquisition in the public market Common Shares 10,000 $0.930 May 09/05 May 04/05 Friesen, Albert David 10 - Acquisition in the public market Common Shares 8,500 $0.940 May 09/05 May 04/05 Friesen, Albert David 10 - Acquisition in the public market Common Shares 1,000 $0.900
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse